CoChat

Reduced Final Height Outcome in Congenital Adrenal Hyperplasia under Prednisone Treatment: Deceleration of Growth Velocity during Puberty

Bonfig, Walter, Bechtold, Susanne, Schmidt, Heinrich, Knorr, Dietrich, Schwarz, Hans Peter · 2007 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.

Abstract

CONTEXT: Normal to decreased final height (FH) has been reported in patients with congenital adrenal hyperplasia (CAH). OBJECTIVE: The objective was to determine FH outcome and influences of steroid treatment. METHODS: The effects of glucocorticoid treatment for classical CAH were retrospectively studied in 125 patients (77 females). Growth pattern, FH, and pubertal development were recorded. RESULTS: Corrected FH was in the lower range of genetic potential [females with simple virilizing (SV)-CAH, -0.6 +/- 1.0 sd score (SDS) vs. females with salt-wasting (SW)-CAH, -0.6 +/- 0.9 SDS; males with SV-CAH, -1.1 +/- 0.9 SDS vs. males with SW-CAH, -0.9 +/- 0.9 SDS]. Total pubertal growth was significantly reduced in comparison with a reference population (females with SV-CAH, 11.9 +/- 6.5 cm, and females with SW-CAH, 13.8 +/- 7.6 cm vs. reference 20.3 +/- 6.8 cm, P < 0.01; and males with SV-CAH, 15.4 +/- 6.6 cm, and males with SW-CAH, 18.5 +/- 6.9 cm vs. reference 28.2 +/- 8.2 cm, P < 0.01). Thirty-three patients had been treated with prednisone, which resulted in reduced FH compared with patients (n = 92) treated with hydrocortisone (-1.0 +/- 0.9 SDS vs.-0.6 +/- 0.9 SDS; P < 0.05). FH correlated negatively with hydrocortisone dose given at the start of puberty (r = -0.3; P < 0.05). Pubertal development started early in boys [9.8 +/- 2.3 yr (SV) and 10.6 +/- 1.9 yr (SW)] and was timely in girls [9.8 +/- 1.9 yr (SV) and 10.3 +/- 1.5 yr (SW), menarche at 13.3 +/- 1.7 yr (SV) and 13.7 +/- 1.5 yr (SV)]. CONCLUSION: Patients with CAH are able to achieve adequate FH with conventional therapy. Total pubertal growth is significantly decreased, and treatment with prednisone results in decreased FH. In addition to biochemical analysis, treatment should be adjusted to normal growth velocity, especially during puberty.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2006-2109

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 167

Metadata

Authors
Bonfig, W., Bechtold, S., Schmidt, H., Knorr, D., & Schwarz, H. P.
Affiliations
Ludwig-Maximilians-Universität München (DE)
Corresponding author
Bonfig, Walter
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2007-05-01
Volume
92
Issue
5
Pages
1635-1639
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2160090915
Cited by
167
References
40
Citations by year
2026: 10 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 6 · 2019: 15 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 1 · 2014: 8 · 2013: 11 · 2012: 6
FWCI
5.03
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
congenital adrenal hyperplasia, adult height, prednisone, cortisol, glucocorticoid therapy, growth rate, puberty, pubertal growth, simple virilizing CAH, salt-wasting CAH, menarche, growth hormone therapy, genetic potential, dose-response relationship, short stature, children and adolescents, sex differences, puberty timing
MeSH terms
Adolescent, Adrenal Hyperplasia, Congenital, Body Height, Breast, Child, Female, Growth, Hormones, Humans, Hydrocortisone, Male, Prednisone, Puberty, Retrospective Studies, Steroid 21-Hydroxylase, Testis, Body Mass Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.